Pacs (PACS) | Financial Analysis & Statements
Pacs Group Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
1.4B
Gross Profit
223.6M
16.46%
Operating Income
94.7M
6.97%
Net Income
59.8M
4.40%
Balance Sheet Metrics
Total Assets
5.6B
Total Liabilities
4.6B
Shareholders Equity
952.4M
Debt to Equity
4.86
Cash Flow Metrics
Operating Cash Flow
126.4M
Free Cash Flow
-117.7M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Pacs Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 5.3B | 4.1B | 3.1B | 2.4B | 1.2B |
| Cost of Goods Sold | 4.5B | 3.6B | 2.7B | 2.0B | 979.2M |
| Gross Profit | 780.3M | 507.7M | 447.1M | 400.7M | 187.3M |
| Gross Margin % | 14.8% | 12.4% | 14.4% | 16.5% | 16.1% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 415.1M | 343.8M | 213.7M | 149.0M | 96.8M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 415.1M | 343.8M | 213.7M | 149.0M | 96.8M |
| Operating Income | 309.6M | 123.1M | 207.8M | 229.4M | 83.4M |
| Operating Margin % | 5.9% | 3.0% | 6.7% | 9.5% | 7.1% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 28.4M | 44.3M | 49.9M | 25.5M | 5.3M |
| Other Non-Operating Income | 3.2M | 22.8M | -536.0K | 3.2M | 3.3M |
| Pre-tax Income | 284.4M | 101.6M | 157.3M | 207.0M | 81.4M |
| Income Tax | 93.0M | 46.2M | 44.4M | 56.5M | 33.5M |
| Effective Tax Rate % | 32.7% | 45.5% | 28.2% | 27.3% | 41.1% |
| Net Income | 191.5M | 55.3M | 112.9M | 150.5M | 47.9M |
| Net Margin % | 3.6% | 1.4% | 3.6% | 6.2% | 4.1% |
| Key Metrics | |||||
| EBITDA | 368.5M | 178.7M | 232.9M | 254.9M | 93.9M |
| EPS (Basic) | $1.23 | $0.38 | $0.75 | $1.00 | $0.32 |
| EPS (Diluted) | $1.22 | $0.38 | $0.75 | $1.00 | $0.32 |
| Basic Shares Outstanding | 156180786 | 146663371 | 150151958 | 150151958 | 150151958 |
| Diluted Shares Outstanding | 156180786 | 146663371 | 150151958 | 150151958 | 150151958 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Pacs Balance Sheet From 2022 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Current Assets | ||||
| Cash & Equivalents | 197.0M | 157.7M | 73.4M | 58.3M |
| Short-term Investments | - | - | - | - |
| Accounts Receivable | 628.1M | 641.8M | 547.8M | 370.9M |
| Inventory | - | - | - | - |
| Other Current Assets | 170.6M | 64.1M | 48.7M | 32.8M |
| Total Current Assets | 1.1B | 938.3M | 722.1M | 511.2M |
| Non-Current Assets | ||||
| Property, Plant & Equipment | 3.1B | 3.1B | 2.0B | 1.4B |
| Goodwill | 129.9M | 127.9M | 124.3M | 116.7M |
| Intangible Assets | 6.3M | 6.3M | 6.3M | 6.3M |
| Long-term Investments | - | - | - | - |
| Other Non-Current Assets | 189.8M | 186.2M | 140.0M | 113.6M |
| Total Non-Current Assets | 4.5B | 4.3B | 2.8B | 2.0B |
| Total Assets | 5.6B | 5.2B | 3.5B | 2.5B |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts Payable | 192.2M | 175.1M | 140.9M | 110.6M |
| Short-term Debt | 186.5M | 314.3M | 127.2M | 182.4M |
| Current Portion of Long-term Debt | - | - | - | - |
| Other Current Liabilities | - | - | - | - |
| Total Current Liabilities | 1.0B | 978.4M | 456.9M | 483.9M |
| Non-Current Liabilities | ||||
| Long-term Debt | 3.3B | 3.2B | 2.7B | 1.7B |
| Deferred Tax Liabilities | - | - | - | - |
| Other Non-Current Liabilities | 152.9M | 197.0M | 123.5M | 37.1M |
| Total Non-Current Liabilities | 3.6B | 3.5B | 3.0B | 1.9B |
| Total Liabilities | 4.6B | 4.5B | 3.4B | 2.4B |
| Equity | ||||
| Common Stock | 157.0K | 155.0K | 129.0K | 129.0K |
| Retained Earnings | 309.6M | 118.0M | 96.0M | 63.5M |
| Treasury Stock | - | - | - | - |
| Other Equity | - | - | - | - |
| Total Shareholders Equity | 952.4M | 715.7M | 101.7M | 68.7M |
| Key Metrics | ||||
| Total Debt | 3.5B | 3.5B | 2.8B | 1.9B |
| Working Capital | 68.3M | -40.2M | 265.2M | 27.3M |
Balance Sheet Composition
Pacs Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 191.5M | 55.3M | 112.9M | 150.5M | 47.9M |
| Depreciation & Amortization | 55.7M | 40.8M | 25.6M | 22.3M | 7.2M |
| Stock-Based Compensation | 54.1M | 115.5M | - | - | - |
| Working Capital Changes | 7.4M | -17.1M | -62.3M | -125.6M | -33.5M |
| Operating Cash Flow | 343.0M | 187.9M | 95.1M | 61.0M | 31.7M |
| Investing Activities | |||||
| Capital Expenditures | -249.2M | -349.8M | -172.8M | -78.2M | -203.8M |
| Acquisitions | 0 | -32.9M | -2.6M | 0 | -15.7M |
| Investment Purchases | -21.2M | -90.9M | - | - | - |
| Investment Sales | 0 | 25.9M | - | - | - |
| Investing Cash Flow | -269.6M | -446.2M | -174.7M | -78.2M | -219.5M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | 0 | -33.7M | -80.4M | -60.3M | -53.8M |
| Debt Issuance | 0 | 748.3M | 1.3B | 242.4M | 622.4M |
| Debt Repayment | -60.2M | -1.1B | -1.1B | -173.0M | -386.6M |
| Financing Cash Flow | -69.0M | 117.5M | 129.6M | 12.4M | 182.0M |
| Free Cash Flow | 155.1M | 17.5M | -109.1M | 14.4M | -146.2M |
| Net Change in Cash | 4.4M | -140.8M | 50.0M | -4.9M | -5.8M |
Cash Flow Trend
Pacs Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
28.73
Forward P/E
14.85
Price to Book
5.80
Price to Sales
1.04
PEG Ratio
14.85
Profitability Ratios
Profit Margin
3.62%
Operating Margin
6.97%
Return on Equity
22.96%
Return on Assets
3.57%
Financial Health
Current Ratio
1.07
Debt to Equity
377.77
Beta
0.06
Per Share Data
EPS (TTM)
$1.22
Book Value per Share
$6.05
Revenue per Share
$33.86
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| PACS | 5.5B | 28.73 | 5.80 | 22.96% | 3.62% | 377.77 |
| HCA Healthcare | 106.0B | 16.86 | -38.44 | -244.82% | 8.97% | -17.57 |
| Tenet Healthcare | 16.5B | 12.17 | 3.88 | 27.02% | 6.60% | 160.79 |
| Chemed | 5.6B | 20.88 | 5.36 | 25.28% | 10.48% | 14.68 |
| Option Care Health | 4.5B | 22.35 | 3.36 | 15.20% | 3.67% | 96.00 |
| Amedisys | 3.3B | 39.30 | 2.69 | 6.67% | 3.56% | 35.34 |
Financial data is updated regularly. All figures are in the company's reporting currency.





